These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 36985296

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A, Jamioł-Milc D, Hawryłkowicz V, Skonieczna-Żydecka K, Stachowska E.
    Nutrients; 2022 Dec 09; 14(24):. PubMed ID: 36558421
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.
    Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, Ray P, Dhiman RK, Chawla Y.
    J Gastroenterol Hepatol; 2016 Jan 09; 31(1):213-21. PubMed ID: 26212089
    [Abstract] [Full Text] [Related]

  • 5. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.
    Fitriakusumah Y, Lesmana CRA, Bastian WP, Jasirwan COM, Hasan I, Simadibrata M, Kurniawan J, Sulaiman AS, Gani RA.
    BMC Gastroenterol; 2019 Mar 20; 19(1):43. PubMed ID: 30894137
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth.
    Rafiei R, Bemanian M, Rafiei F, Bahrami M, Fooladi L, Ebrahimi G, Hemmat A, Torabi Z.
    Rom J Intern Med; 2018 Jun 01; 56(2):85-89. PubMed ID: 29101772
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
    Gudan A, Kozłowska-Petriczko K, Wunsch E, Bodnarczuk T, Stachowska E.
    Nutrients; 2023 Mar 08; 15(6):. PubMed ID: 36986052
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.
    Domper Bardají F, Gil Rendo A, Illescas Fernández-Bermejo S, Patón Arenas R, Hernández Albújar A, Martín Dávila F, Murillo Lázaro C, Sánchez Alonso M, Serrano Dueñas M, Sobrino López A, Ramírez Esteso F, Martín Fernández J.
    Rev Esp Enferm Dig; 2019 Apr 08; 111(4):294-300. PubMed ID: 30896956
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
    McGlinchey AJ, Govaere O, Geng D, Ratziu V, Allison M, Bousier J, Petta S, de Oliviera C, Bugianesi E, Schattenberg JM, Daly AK, Hyötyläinen T, Anstee QM, Orešič M.
    JHEP Rep; 2022 May 08; 4(5):100477. PubMed ID: 35434590
    [Abstract] [Full Text] [Related]

  • 16. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK.
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr 01; 316(4):G462-G472. PubMed ID: 30653341
    [Abstract] [Full Text] [Related]

  • 17. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
    Xu ZJ, Shi JP, Yu DR, Zhu LJ, Jia JD, Fan JG.
    Adv Ther; 2016 Nov 01; 33(11):2069-2081. PubMed ID: 27743352
    [Abstract] [Full Text] [Related]

  • 18. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
    Belei O, Olariu L, Dobrescu A, Marcovici T, Marginean O.
    J Pediatr Endocrinol Metab; 2017 Oct 26; 30(11):1161-1168. PubMed ID: 28988228
    [Abstract] [Full Text] [Related]

  • 19. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
    Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, Tan DJH, Tang ASP, Tay P, Xiao J, Yong JN, Zeng RW, Chew NWS, Nah B, Kulkarni A, Siddiqui MS, Dan YY, Wong VW, Sanyal AJ, Noureddin M, Muthiah M, Ng CH.
    Lancet Gastroenterol Hepatol; 2023 Jan 26; 8(1):20-30. PubMed ID: 36400097
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.